Search research articles
Contact Us
Filters
Showing results (121-130 of 128) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 128 results.
Leukemia Research
|
April 11, 2022
Response to azacitidine in patients with chronic myelomonocytic leukemia according to overlap myelodysplastic/myeloproliferative neoplasms criteria
A Triguero, B Xicoy, L Zamora, et al.
Nature Communications
|
March 20, 2021
CRISPRi screens reveal a DNA methylation-mediated 3D genome dependent causal mechanism in prostate cancer
Musaddeque Ahmed, Fraser Soares, Ji-Han Xia, et al.
Cancer Discovery
|
December 9, 2024
Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer
Lisa N Chesner, Fanny Polesso, Julie N Graff, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2025
Genome-wide CRISPR screens identify PTGES3 as a novel AR modulator
Haolong Li, James E Melnyk, Becky Xu Hua Fu, et al.
Nature Genetics
|
November 5, 2025
Genome-scale CRISPR screens identify PTGES3 as a direct modulator of androgen receptor function in advanced prostate cancer
Haolong Li, James E Melnyk, Becky Xu Hua Fu, et al.
International Journal of Stroke : Official Journal of the International Stroke Society
|
October 8, 2025
Reperfusion-dependent treatment effects of thrombectomy in patients with large ischemic infarcts
Lukas Meyer, Susanne Gellißen, Götz Thomalla, et al.
Cancer Research
|
October 17, 2022
The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
Martin Sjöström, Shuang G Zhao, Samuel Levy, et al.
Nature Genetics
|
July 15, 2020
The DNA methylation landscape of advanced prostate cancer
Shuang G Zhao, William S Chen, Haolong Li, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 128) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 128 results.
Leukemia Research
|
April 11, 2022
Response to azacitidine in patients with chronic myelomonocytic leukemia according to overlap myelodysplastic/myeloproliferative neoplasms criteria
A Triguero, B Xicoy, L Zamora, et al.
Nature Communications
|
March 20, 2021
CRISPRi screens reveal a DNA methylation-mediated 3D genome dependent causal mechanism in prostate cancer
Musaddeque Ahmed, Fraser Soares, Ji-Han Xia, et al.
Cancer Discovery
|
December 9, 2024
Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer
Lisa N Chesner, Fanny Polesso, Julie N Graff, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2025
Genome-wide CRISPR screens identify PTGES3 as a novel AR modulator
Haolong Li, James E Melnyk, Becky Xu Hua Fu, et al.
Nature Genetics
|
November 5, 2025
Genome-scale CRISPR screens identify PTGES3 as a direct modulator of androgen receptor function in advanced prostate cancer
Haolong Li, James E Melnyk, Becky Xu Hua Fu, et al.
International Journal of Stroke : Official Journal of the International Stroke Society
|
October 8, 2025
Reperfusion-dependent treatment effects of thrombectomy in patients with large ischemic infarcts
Lukas Meyer, Susanne Gellißen, Götz Thomalla, et al.
Cancer Research
|
October 17, 2022
The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
Martin Sjöström, Shuang G Zhao, Samuel Levy, et al.
Nature Genetics
|
July 15, 2020
The DNA methylation landscape of advanced prostate cancer
Shuang G Zhao, William S Chen, Haolong Li, et al.
Page
of 13